Tag: Heart Failure
FDA Expands Approval of Jardiance for Patients With Heart Failure
Jardiance received approval to reduce the risk for cardiovascular death and hospitalization for patients with heart failure
SGLT2is, SGLT2i/GLP-1RA May Prevent CV Events in T2DM
Current use of SGLT2is, GLP-1RAs, and their combination associated with significantly reduced risk of heart failure events
Atrial Shunt No Benefit for Heart Failure With Preserved EF
Subgroup analysis indicates treatment efficacy differed with presence or absence of pulmonary vascular disease unmasked by exercise
Risk for Heart Failure Cut With Faster Walking Speed
Older women who walk at an average or fast pace have lower risk for heart failure versus slower walkers
POCUS Measure of JVP Predicts Elevated CVP in Heart Failure
Point-of-care ultrasonography assessment of jugular venous pressure height can predict elevated right atrial pressure
SGLT2 Inhibitor Use May Benefit Patients With HFpEF
SGLT2 inhibitor use may reduce the risk for CV death or hospitalization for heart failure in HF patients with preserved ejection fraction
Aspirin Use Tied to Incident Heart Failure in At-Risk Adults
Aspirin use associated with increased risk for incident heart failure among individuals with or without a history of cardiovascular disease
Genetic Links Between Schizophrenia, CVD Explored
Genetic correlations between schizophrenia and CVD close to zero, but schizophrenia liability may increase heart failure risk
Sacubitril-Valsartan Does Not Cut Risk for Death, Heart Failure After MI
Sacubitril-valsartan not linked to reduced incidence of death from cardiovascular causes or incident heart failure versus ramipril
AHA: Use of Cardiac Rehab Low in Adults With Heart Failure
Rate of enrollment increased after Medicare expansion in 2014, but absolute enrollment rate in cardiac rehabilitation for HF patients still low
